90
Views
1
CrossRef citations to date
0
Altmetric
REVIEW

UC blood-derived mesenchymal stromal cells: an overview

, &
Pages 717-726 | Published online: 07 Jul 2009

References

  • Fitzgerald MJT, Fitzgerald M, Lee G. Introduction. Human Embryology: A Human Approach, MJT Fitzgerald, M. Fitzgerald. Bailliere Tindall, London 1994; 2–6
  • Lee OK, Kuo TK, Chen WM, et al. Isolation of mesenchymal stem cells from umbilical cord blood. Blood 2004; 103: 1669–75
  • D'Ippolito G, Schiller PC, Ricordi C, et al. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 1999; 14: 1115–22
  • Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal stem cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309–13
  • Bieback K, Kern S, Kluter H, et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004; 22: 625–34
  • Wagner W, Wein F, Seckinger A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005; 33: 1402–16
  • Chang YJ, Tseng CP, Hsu LF, et al. Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood. Cell Biol Int 2006; 30: 495–9
  • Romanov Y, Svintsitskaya V, Smirnov V. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003; 21: 105–10
  • Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294–301
  • Yen BL, Huang HI, Chien CC, et al. Isolation of multipotent cells from human term placenta. Stem Cells 2005; 23: 3–9
  • Wang HS, Hung SC, Peng ST, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004; 22: 1330–7
  • Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–7
  • Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36: 568–84
  • Jiang Y, Jahagirdar N, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41–9
  • Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med 2001; 226: 507–20
  • Barry FP, Boynton RE, Liu B, et al. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 2001; 268: 189–200
  • Gang EJ, Hong SH, Jeong JA, et al. In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells. Biochem Biophys Res Commun 2004; 321: 102–8
  • Lee MW, Choi J, Yang MS, et al. Mesenchymal stem cells from cryopreserved human umbilical cord blood. Biochem Biophys Res Commun 2004; 320: 273–8
  • Kang XQ, Zang WJ, Bao LJ, et al. Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes. World J Gastroenterol 2005; 11: 7461–5
  • Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006; 91: 1017–26
  • Tondreau T, Meuleman N, Delforge A, et al. Mesenchymal stem cells derived from CD133-positive cells in mobilised peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005; 23: 1105–12
  • Gang EJ, Jeong JA, Hong SH, et al. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 2004; 22: 617–24
  • Caplan A, Dennis J. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076–84
  • Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anaemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–8
  • Kim J, Lee Y, Kim H, et al. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif 2007; 40: 75–90
  • Kogler G, Sensken S, Airey JA, et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200: 123–35
  • Sparrow RL, Cauchi JA, Ramadi LT, et al. Influence of mode of birth and collection on WBC yields of umbilical cord blood units. Transfusion 2002; 42: 210–5
  • McGuckin CP, Pearce D, Forraz N, et al. Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur J Haematol 2003; 71: 341–50
  • Mancinelli F, Tambirini A, Spagnoli A, et al. Optimizing umbilical cord blood collection: impact of obstetric factors versus quality of cord blood units. Transplant Proc 2006; 38: 1174–6
  • Lim FT, van Winsen L, Willemze R, et al. Influence of delivery on numbers of leukocytes, leukocyte subpopulations, and hematopoietic progenitor cells in human umbilical cord blood. Blood Cells 1994; 20: 547–58
  • Surbek DV, Schönfeld B, Tichelli A, et al. Optimizing cord blood mononuclear yield: a randomized comparison of collection before vs. after placental delivery. Bone Marrow Transplant 1998; 22: 311–2
  • Donaldson C, Armitage WJ, Laundy V, et al. Impact of obstetric factors on cord blood donation for transplantation. Br J Haematol 1999; 106: 128–32
  • Nakagawa R, Watanabe T, Kawano Y, et al. Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking. Transfusion 2004; 44: 262–7
  • Wexler SA, Donaldson C, Denning-Kendall P, et al. Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not. Br J Haematol 2003; 121: 368–74
  • Potian JA, Aviv H, Ponzio NM, et al. Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 2003; 171: 3426–34
  • Liu CH, Hwang SM. Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 2005; 32: 270–9
  • Martinez C, Hofmann TJ, Marino R, et al. Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood 2007; 109: 4245–8
  • Götherström C, Ringdén O, Tammik C, et al. Immunologic properties of human fetal mesenchymal stem cells. Am J Obst Gynecol 2004; 190: 239–45
  • Talens-Visconti R, Bonora A, Jover R, et al. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World J Gastroenterol 2006; 12: 5834–45
  • Klassen HJ, Imfeld KL, Kirov II, et al. Expression of cytokines by multipotent neural progenitor cells. Cytokine 2003; 22: 101–6
  • Chen CC, Manning AM. TGF-beta, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 1996; 8: 58–65
  • Lambert E, Dasse E, Haye B, et al. TIMPs as multifacial proteins. Crit Rev Oncol Hematol 2004; 49: 187–98
  • Jia L, Young MF, Powell J, et al. Gene expression profile of human bone marrow stromal cells: high-throughput expressed sequence tag sequencing analysis. Genomics 2002; 79: 7–17
  • Monticone M, Liu Y, Tonachini L, et al. Gene expression profile of human bone marrow stromal cells determined by restriction fragment differential display analysis. J Cell Biochem 2004; 92: 733–44
  • Jeong JA, Hong SH, Gang EJ, et al. Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells 2005; 23: 584–93
  • Panepucci R, Siufi J, Silva W, Jr, et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004; 22: 1263–78
  • Feldman R, Jr, Bieback K, Maurer M, et al. Stem cell proteomes: a profile of human mesenchymal stem cells derived from umbilical cord blood. Electrophoresis 2005; 26: 2749–58
  • Jeong JA, Lee Y, Lee W, et al. Proteomic analysis of the hydrophobic fraction of mesenchymal stem cells derived from human umbilical cord blood. Mol Cells 2006; 22: 36–43
  • Rosada C, Justesen J, Melsvik D, et al. The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcif Tissue Int 2003; 72: 135–42
  • Maurer, MH, Feldmann, RE, Jr, Fütterer, CD, , et al. The proteome of neural stem cells from adult rat hippocampus. Proteome Sci 2003;1:4
  • Zensmaier C, Gesslbauer B, Grobuschek N, et al. Proteomic profiling of human stem cells derived from umbilical cord blood. Biochem Biophys Res Commun 2005; 328: 968–72
  • Ma N, Ladilov Y, Moebius J, et al. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: bone marrow vs. cord blood-derived cells. Cardiovasc Res 2006; 71: 158–69
  • Henning RJ, Abu-Ali H, Balis JU, et al. Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant 2004; 13: 729–39
  • Nishiyama, N, Miyoshi, S, Hida, N, , et al. The significant cardiomyogenic potential of human umbilical cord blood-derived mesenchymal stem cells in vitro. Stem Cells 2007;25:2017–24. 10 May [Epub ahead of print].
  • Kim SW, Han H, Chae GT, et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischaemic limb disease animal model. Stem Cells 2006; 24: 1620–6
  • Roussos I, Rodriguez M, Villan D, et al. Development of a rat model of spinal cord injury and cellular transplantation. Transplant Proc 2005; 37: 4127–30
  • Saporta S, Kim JJ, Willing AE, et al. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behaviour. J Hematother Stem Cell Res 2003; 12: 271–8
  • Willing AE, Vendrame M, Mallery J, et al. Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant 2003; 12: 449–54
  • Garbuzova-Davis S, Willing AE, Zigova T, et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. J Hematother Stem Cell Res 2003; 12: 255–70
  • Gnecchi M, He H, Liang OD. Paracrine action accounts for marked protection of ischaemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005; 11: 367–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.